Looking from 2023 to 2024, the latest year of data available, prescriptions and gross spending for Wegovy (first approved for obesity in 2021, approved for cardiovascular disease in 2024) and Mounjaro (approved for type 2 diabetes in 2022) more than doubled, and prescriptions and gross spending for Zepbound (first approved for obesity in 2023, approved for sleep apnea in 2024) increased more than fivefold
These symptoms are often worse when meals are large, greasy, spicy, or eaten too fast
HSA and FSA cards are accepted, and PlexusDx works with patients across all 50 states, eliminating geographic barriers to accessing evidence-based weight loss therapy
The prolonged half-life of GLP-1 analogs is achieved through several mechanisms, such as delayed absorption from the subcutaneous injection site, albumin binding, which shields the molecule from enzymatic degradation by DPP-4, and reduced renal clearance
Patient-specific 503A compounding can still occur for documented medical needs that the FDA-approved version cannot meet, but mass-market online sales of compounded tirzepatide no longer have a clear legal basis
Drug interactions The blood-sugar-lowering effects of chromium, fenugreek, and white mulberry leaf could theoretically interact with other medications that affect blood sugar
&srotate=0)
